drugset / Trial / NCT07650851
Clinical Study on the Efficacy and Safety of Nalfurafine Hydrochloride Orally Disintegrating Tablets in Treating Pruritus in Patients Undergoing Maintenance Hemodialysis
Not yet recruiting
150 enrolled
Chinese PLA General Hospital
Beijing Friendship Hospital · collabChengdu First People's Hospital · collabDaping Hospital of Army Medical University · collabFirst Affiliated Hospital Xi'an Jiaotong University · collabFirst Affiliated Hospital of Wannan Medical College · collabHenan Provincial People's Hospital · collabJiangsu Taizhou People's Hospital · collabQilu Hospital of Shandong University · collabRenJi Hospital · collabShanghai Changzheng Hospital · collabSun Yat-Sen Memorial Hospital of Sun Yat-Sen University · collabThe First Affiliated Hospital of Dalian Medical University · collabThe General Hospital of Northern Theater Command · collabThe People's Hospital of Leshan · collabThe Third Affiliated Hospital of Wenzhou Medical University · collabTianjin First Central Hospital · collabXiangyang Central Hospital · collabXinhua Hospital, Shanghai Jiao Tong University School of Medicine · collabZigong No.1 Peoples Hospital · collab
RandomizedParallel-groupOpen-labelTreatment
Summary
This is a randomized, open-label, multi-center clinical study aimed at evaluating the efficacy and safety of 12 weeks of nalfurafine hydrochloride administration in the treatment of pruritus in patients undergoing maintenance hemodialysis.
Timeline
- Start
- 2026-07-01
- Primary completion
- 2028-12-31
- Completion
- 2028-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Nalfurafine | Small molecule | 2.5 ug | Oral |
Indications
No indication recorded.